By: Alyssa Wilson Pfizer is getting ready to seek authorization in the United States for a third dose of its COVID-19 vaccine. On Thursday, the company said another dose within 12 months could boost immunity and help fight the highly transmissible variants of the disease. According to the Associated Press, research from multiple countries revealed the Pfizer shot and other COVID-19 vaccines offer protection against the Delta variant spreading quickly in the United States. While two doses are needed to develop the antibodies to fight COVID-19 and its variants, antibodies can dwindle over time. RELATED: Pfizer COVID-19 Vaccine Offers Six Months of Protection, Clinical Trial Shows […]
The post Pfizer Will Seek Approval for Third Dose of COVID-19 Vaccine appeared first on BNC.
